Drug Shortage Report for TOMUDEX
| Report ID | 2496 |
| Drug Identification Number | 02229566 |
| Brand name | TOMUDEX |
| Common or Proper name | Raltitrexed powder |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TOMUDEX |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS / INTRAVEINEUSE |
| Packaging size | VIAL / AMPOULE |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-04-14 |
| Actual start date | |
| Estimated end date | 2017-05-25 |
| Actual end date | 2017-05-25 |
| Shortage status | Resolved |
| Updated date | 2017-06-01 |
| Company comments | Resolved May 25, 2017 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-03-14 | English | Compare |
| v2 | 2017-03-14 | French | Compare |
| v3 | 2017-03-22 | English | Compare |
| v4 | 2017-03-22 | French | Compare |
| v5 | 2017-03-22 | French | Compare |
| v6 | 2017-03-22 | English | Compare |
| v7 | 2017-03-22 | French | Compare |
| v8 | 2017-03-28 | English | Compare |
| v9 | 2017-03-28 | English | Compare |
| v10 | 2017-03-28 | French | Compare |
| v11 | 2017-03-29 | English | Compare |
| v12 | 2017-03-29 | French | Compare |
| v13 | 2017-03-30 | English | Compare |
| v14 | 2017-03-30 | French | Compare |
| v15 | 2017-04-15 | English | Compare |
| v16 | 2017-04-28 | English | Compare |
| v17 | 2017-04-28 | French | Compare |
| v18 | 2017-06-01 | English | Compare |
| v19 | 2017-06-01 | French | Compare |
Showing 1 to 19 of 19